Phase I study of N6-benzyladenosine-5'-monophosphate.
D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D004341:Drug Evaluation; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D012509:Sarcoma / Q000188:drug therapy
D000970:Antineoplastic Agents; D000249:Adenosine Monophosphate